A Review of Xeris Biopharma Holdings Inc (NASDAQ: XERS)’s Performance and Growth Prospects

NOVA

In the last trading session, 2.64 million Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares changed hands as the company’s beta touched 0.69. With the company’s per share price at $5.08 changed hands at $0.21 or 4.31% during last session, the market valuation stood at $813.58M. XERS’s last price was a discount, traded about -19.49% off its 52-week high of $6.07. The share price had its 52-week low at $1.86, which suggests the last value was 63.39% up since then.

Analysts gave the Xeris Biopharma Holdings Inc (XERS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.33. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended XERS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.

Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information

Instantly XERS was in green as seen at the end of in last trading. With action 3.67%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 49.85%, with the 5-day performance at 3.67% in the green. However, in the 30-day time frame, Xeris Biopharma Holdings Inc (NASDAQ:XERS) is 26.37% up.

The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need a downside of -27.0% from its current market value. According to analyst projections, XERS’s forecast low is 4 with 4 as the target high. To hit the forecast high, the stock’s price needs a 21.26% surge from its current level, while the stock would need to tank 21.26% for it to hit the projected low.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.01%. The 2025 estimates are for Xeris Biopharma Holdings Inc earnings to increase by 79.28%.

XERS Dividends

Xeris Biopharma Holdings Inc is expected to release its next quarterly earnings report in June.

VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.1615% or 7.66 million shares worth $17.23 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 4.22 shares estimated at $21.44 million under it, the former controlled 2.70% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.37% of the shares, roughly 3.71 shares worth around $18.83 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.